This Coinbase Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

Citizens Reiterates Market Outperform on Affirm Holdings, Maintains $85 Price Target

Citizens analyst David Scharf reiterates Affirm Holdings (NASDAQ:AFRM) with a Market Outperform and maintains $85 price target.

Affirm Holdings (AFRM) Rises As Market Takes a Dip: Key Facts

Affirm Holdings (AFRM) closed at $73.55, up 2.95% on the day, outperforming the broader market decline. The company is expected to report EPS of $0.34 (up 47.83% YoY) and revenue of $1.21 billion (up 29.95% YoY). However, full-year earnings are projected to decline 66.18% YoY. AFRM trades at a Forward P/E of 38.13, significantly above its industry average of 19.75, and carries a Zacks Rank #3 (Hold) rating.

Wolfe Research Upgrades Affirm Holdings to Outperform, Announces $90 Price Target

Wolfe Research analyst Darrin Peller upgrades Affirm Holdings (NASDAQ:AFRM) from Peer Perform to Outperform and announces $90 price target.

Shares of crypto-linked stocks are trading lower amid a drop in Bitcoin as the sector continues to react to the U.S. Senate's vote against advancing the Clarity Act. The defeat delays a regulatory framework for the crypto industry.

Kestra Medical Technologies Posts Mixed Q1 Results, Joins Enova International, Dave and Buster's And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Kestra Medical fell 8.6% after missing earnings estimates despite beating sales forecasts; several other stocks also declined premarket.

Bullish shares are trading higher after Compass Point upgraded the stock from Neutral to Buy rating and raised its price target from $30 to $51.